These windows of opportunity aren't likely to remain open for much longer.
Investors looking for stocks that can make dramatic gains can find some in the biopharmaceutical industry. Right now, there are a pair of biopharma stocks that Wall Street expects to rocket higher in 2025....
It hasn't been a great year for Iovance Biotherapeutics (NASDAQ: IOVA), an innovative mid-cap biotech company. The drugmaker's shares have significantly lagged the market -- advancing only about 5% so...
Just be ready to ride out some inevitable turbulence along the way.
The biotech industry has been described as the Wild West of the stock market. Although some companies manage to develop and commercialize a life-changing therapeutic, countless more start-ups inevitably...
As the rising star of cell therapy biotechs, Iovance Biotherapeutics (NASDAQ: IOVA) is a hot stock that's capturing a lot of attention, and for good reason. Iovance's one-of-a-kind medicine is already...
Many of Wall Street's largest and most successful stocks became so thanks to innovation. It's too late to get in on the ground floor with those that are already well-established leaders in their fields,...
Biotechs often need several years to realize their visions, even after they have a drug approved for the first time. There's typically plenty of upside in store for enterprising and patient investors.